AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )
2.710
+0.580
(+27.23%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2024
Add to My Watchlist
All News about AN2 Therapeutics, Inc. - Common Stock
Via Benzinga
Via Benzinga
Nasdaq Edges Lower; ContextLogic Shares Surge
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
February 12, 2024
Via Benzinga
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Mixed; Trimble Issues Weak Outlook
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 12, 2024
Via Benzinga
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 06, 2023
Via Business Wire
AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023
October 11, 2023
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
August 17, 2023
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.